https://doi.org/10.4081/reumatismo.2024.1638
Disease activity assessment for juvenile idiopathic arthritis in transitional care
Accepted: 24 March 2024
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Objective. The indices to measure disease activity of chronic arthritis in adulthood and childhood are different. Therefore, assessing the status of the disease in young patients with juvenile idiopathic arthritis (JIA) can be tricky, especially when the transition to adult care is ongoing. The aim of our study was to assess the level of correlation between adult and juvenile scores in the measurement of disease activity in JIA patients during transitional care.
Methods. We estimated the disease activity by using the Juvenile Arthritis Disease Activity Score 71 (JADAS71), clinical JADAS, adult Disease Activity Score (DAS28), Simplified Disease Activity Index (SDAI), and Clinical Disease Activity Index (CDAI) in JIA patients in transitional care. We enrolled patients older than 16 years at the time of the first transition visit, and disease activity was assessed at baseline and 12 months. Regression analyses were carried out to estimate the level of agreement among the different indices.
Results. We recruited 26 patients with JIA; 11 patients were polyarticular (42.3%) and 15 patients were oligoarticular (53.1%). The mean age at diagnosis was 7.7±3.9 years and the age at the first evaluation was 20.9±3.7 years. The correlation between JADAS71 and DAS28 was r2=0.69, r2=0.86 between JADAS71 and SDAI, and r2=0.81 between JADAS71 and CDAI.
Conclusions. SDAI and JADAS71 showed the best correlation, but a few patients were not captured at the same level of disease activity. New prospective studies with a larger number of patients will be needed in this field.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- M. Ruggiero, A. Conforti, A. Culcasi, C. Mazzanti, G. Sibahi, N. Rani, S. Sartini, A focus on melorheostosis disease: a literature review and case report of femoral-acetabular impingement due to melorheostosis treated with surgical hip osteoplasty , Reumatismo: Vol. 76 No. 1 (2024)
- S. Volpinari, C. Monaldini, J.G. Capone, A. Lo Monaco, R. La Corte, F. Trotta, M. Govoni, Headache in Behçet’s disease: case reports and literature review , Reumatismo: Vol. 61 No. 3 (2009)
- C.A. Mansoor, Z. Shemin, Kikuchi-Fujimoto disease with multiple extra-nodal features - A clinical mimic , Reumatismo: Vol. 71 No. 2 (2019)
- V. Gerloni, I. Pontikaki, M Gattinara, F. Fantini, Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the litterature and personal experience , Reumatismo: Vol. 59 No. 3 (2007)
- S. Soldano, P. Montagna, R. Brizzolara, C. Ferrone, A. Parodio, A. Sulli, B. Seriolo, B. Villaggio, M. Cutolo, Endothelin receptor antagonists: effects on extracellular matrix synthesis in primary cultures of skin fibroblasts from systemic sclerosis patients , Reumatismo: Vol. 64 No. 5 (2012)
- M. Varenna, F. Bertoldo, M. Di Monaco, A. Giusti, G. Martini, M. Rossini, On behalf of SIOMMMS, Endorsed by SIR, Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature , Reumatismo: Vol. 65 No. 4 (2013)
- A. Kessel, I. Rosner, E. Zuckerman, T.D. Golan, E. Toubi, Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection , Reumatismo: Vol. 53 No. 2 (2001)
- G. Ferraccioli, Biologic therapy with anti-TNFa in rheumathoid atrhritis , Reumatismo: Vol. 57 No. s4 (2005)
- C. Sales, F. Oliviero, P. Spinella, The mediterranean diet model in inflammatory rheumatic diseases , Reumatismo: Vol. 61 No. 1 (2009)
- C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco, Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies , Reumatismo: Vol. 75 No. 4 (2023)
<< < 25 26 27 28 29 30 31 32 33 34 > >>
You may also start an advanced similarity search for this article.
